These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 12672253

  • 1. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
    Mikó T, Ligneau X, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H.
    J Med Chem; 2003 Apr 10; 46(8):1523-30. PubMed ID: 12672253
    [Abstract] [Full Text] [Related]

  • 2. Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.
    Mikó T, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H.
    Bioorg Med Chem; 2004 May 15; 12(10):2727-36. PubMed ID: 15110854
    [Abstract] [Full Text] [Related]

  • 3. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.
    Sasse A, Kiec-Kononowicz K, Stark H, Motyl M, Reidemeister S, Ganellin CR, Ligneau X, Schwartz JC, Schunack W.
    J Med Chem; 1999 Feb 25; 42(4):593-600. PubMed ID: 10052966
    [Abstract] [Full Text] [Related]

  • 4. Substituted N-phenylcarbamates as histamine H3 receptor antagonists with improved in vivo potency.
    Reidemeister S, Stark H, Ligneau X, Ganellin CR, Schwartz JC, Schunack W.
    Pharmazie; 2000 Feb 25; 55(2):83-6. PubMed ID: 10723763
    [Abstract] [Full Text] [Related]

  • 5. Search for novel leads for histamine H3-receptor antagonists: oxygen-containing derivatives.
    Stark H, Hüls A, Ligneau X, Arrang JM, Schwartz JC, Schunack W.
    Pharmazie; 1997 Jul 25; 52(7):495-500. PubMed ID: 9266588
    [Abstract] [Full Text] [Related]

  • 6. Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.
    Yates SL, Phillips JG, Gregory R, Pawlowski GP, Fadnis L, Khan MA, Ali SM, Tedford CE.
    J Pharmacol Exp Ther; 1999 May 25; 289(2):1151-9. PubMed ID: 10215699
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development of a new class of nonimidazole histamine H(3) receptor ligands with combined inhibitory histamine N-methyltransferase activity.
    Apelt J, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H.
    J Med Chem; 2002 Feb 28; 45(5):1128-41. PubMed ID: 11855993
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.
    Meier G, Krause M, Hüls A, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H.
    J Med Chem; 2004 May 06; 47(10):2678-87. PubMed ID: 15115409
    [Abstract] [Full Text] [Related]

  • 13. A new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines.
    Apodaca R, Dvorak CA, Xiao W, Barbier AJ, Boggs JD, Wilson SJ, Lovenberg TW, Carruthers NI.
    J Med Chem; 2003 Aug 28; 46(18):3938-44. PubMed ID: 12930154
    [Abstract] [Full Text] [Related]

  • 14. New 1-benzyl-4-hydroxypiperidine derivatives as non-imidazole histamine H3 receptor antagonists.
    Maslowska-Lipowicz I, Figlus M, Zuiderveld OP, Walczynski K.
    Arch Pharm (Weinheim); 2008 Dec 28; 341(12):762-73. PubMed ID: 19009544
    [Abstract] [Full Text] [Related]

  • 15. Novel histamine H(3)-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds.
    Stark H, Sadek B, Krause M, Hüls A, Ligneau X, Ganellin CR, Arrang JM, Schwartz JC, Schunack W.
    J Med Chem; 2000 Oct 19; 43(21):3987-94. PubMed ID: 11052804
    [Abstract] [Full Text] [Related]

  • 16. N-Alkenyl and cycloalkyl carbamates as dual acting histamine H3 and H4 receptor ligands.
    Więcek M, Kottke T, Ligneau X, Schunack W, Seifert R, Stark H, Handzlik J, Kieć-Kononowicz K.
    Bioorg Med Chem; 2011 May 01; 19(9):2850-8. PubMed ID: 21498080
    [Abstract] [Full Text] [Related]

  • 17. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.
    Sadek B, Elz S, Pertz HH, Stark H, Schunack W.
    Inflamm Res; 2004 Aug 01; 53 Suppl 2():S109-15. PubMed ID: 15338060
    [Abstract] [Full Text] [Related]

  • 18. Piperidine variations in search for non-imidazole histamine H(3) receptor ligands.
    Łazewska D, Kuder K, Ligneau X, Schwartz JC, Schunack W, Stark H, Kieć-Kononowicz K.
    Bioorg Med Chem; 2008 Sep 15; 16(18):8729-36. PubMed ID: 18774720
    [Abstract] [Full Text] [Related]

  • 19. Novel carbamates as potent histamine H3 receptor antagonists with high in vitro and oral in vivo activity.
    Stark H, Purand K, Ligneau X, Rouleau A, Arrang JM, Garbarg M, Schwartz JC, Schunack W.
    J Med Chem; 1996 Mar 01; 39(5):1157-63. PubMed ID: 8676353
    [Abstract] [Full Text] [Related]

  • 20. [125I]iodoproxyfan and related compounds: a reversible radioligand and novel classes of antagonists with high affinity and selectivity for the histamine H3 receptor.
    Stark H, Purand K, Hüls A, Ligneau X, Garbarg M, Schwartz JC, Schunack W.
    J Med Chem; 1996 Mar 15; 39(6):1220-6. PubMed ID: 8632428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.